LONG-TERM TOLERABILITY AND SAFETY OF ARIPIPRAZOLE IN THE TREATMENT OF PEDIATRIC PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER

被引：0
|
作者：
Forbes, Robert A. [1 ]
Nyilas, M. [1 ]
Johnson, B. [1 ]
Aurang, C. [1 ]
Owen, R. [2 ]
Iwamoto, T. [1 ]
Carson, W. H. [1 ]
Correll, C. [3 ]
机构：
[1] Otsuka Pharmaceut Dev & Commercializat, Clin Dev, Global Med Affairs, Princeton, NJ USA
[2] Bristol Myers Squibb Co, Clin Dev, Wallingford, CT 06492 USA
[3] Zucker Hillside Hosp, Glen Oaks, NY USA
来源：
SCHIZOPHRENIA BULLETIN | 2009年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：362 / 363
页数：2
相关论文
共 50 条
  • [21] Long-term safety and tolerability of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder
    Lindenmayer, Jean-Pierre
    Khan, Akbar
    Eerdekens, Marielle
    Van Hove, Ilse
    Kushner, Stuart
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 (02) : 138 - 144
  • [22] Aripiprazole for long-term maintenance treatment of schizophrenia
    Van Peborgh, P
    McQuade, RD
    Carson, WH
    Saha, A
    Ingenito, GG
    Ali, M
    Archibald, DG
    JOURNAL OF PSYCHOPHARMACOLOGY, 2004, 18 (03) : A66 - A66
  • [23] Aripiprazole for long-term maintenance treatment of schizophrenia
    McQuade, RD
    Kujawa, M
    Saha, AR
    Ingenito, GG
    Ali, MW
    Luo, X
    Archibald, DG
    Carson, WH
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 295 - 295
  • [24] Aripiprazole for long-term maintenance treatment of schizophrenia
    McQuade, R
    Carson, W
    Saha, A
    Ingenito, G
    Ali, M
    Archibald, D
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S288 - S288
  • [25] Aripiprazole for long-term maintenance treatment of schizophrenia
    Gismondi, R
    McQuade, RD
    Carson, WH
    Saha, A
    Ingenito, GG
    Ali, M
    Archibald, DG
    EUROPEAN PSYCHIATRY, 2004, 19 : 177S - 177S
  • [26] Efficacy, Long-Term Safety, and Tolerability of Ziprasidone in Children and Adolescents with Bipolar Disorder
    Findling, Robert L.
    Cavus, Idil
    Pappadopulos, Elizabeth
    Vanderburg, Douglas G.
    Schwartz, Jeffrey H.
    Gundapaneni, Balarama K.
    DelBello, Melissa P.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2013, 23 (08) : 545 - 557
  • [27] Aripiprazole for long-term maintenance treatment of schizophrenia
    McQuade, RD
    Kujawa, M
    Saha, A
    Ingenito, GG
    Ali, M
    Archibald, DG
    Carson, WH
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 176S - 176S
  • [28] THE LONG-TERM SAFETY, TOLERABILITY AND EFFECTIVENESS OF ADJUNCTIVE ARIPIPRAZOLE TO LITHIUM/VALPROATE IN BIPOLAR I PATIENTS PARTIALLY NON-RESPONSIVE TO MOOD STABILISERS
    Vieta, E.
    Owen, R.
    Baudelet, C.
    McQuade, R.
    Sanchez, R.
    Fyans, P.
    Loze, J. -Y.
    Marcus, R.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [29] Safety And Tolerability of Aripiprazole 2-Month Ready-to-Use 960 mg in Adult Patients With Schizophrenia or Bipolar I Disorder
    Harlin, Matthew
    Yildirim, Murat
    Such, Pedro
    Madera-McDonough, Jessica
    Jan, Michael
    Larsen, Frank
    CNS SPECTRUMS, 2023, 28 (02) : 237 - 238
  • [30] Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder
    Kunz, Dieter
    Dauvilliers, Yves
    Benes, Heike
    Garcia-Borreguero, Diego
    Plazzi, Giuseppe
    Seboek Kinter, Dalma
    Coloma, Preciosa
    Rausch, Magdalene
    Sassi-Sayadi, Mouna
    Thein, Stephen
    CNS DRUGS, 2023, 37 (01) : 93 - 106
12345